According to the FDA (2024), Sotalol must be initiated in a hospital setting with at least 3 days of continuous EKG monitoring due to the risk of Torsades de Pointes.
A study published in the Journal of the American College of Cardiology (2022) found that Sotalol-induced proarrhythmia occurs in approximately 1% to 4% of patients, with the risk being dose-dependent.
The American Heart Association (AHA, 2023) guidelines state that Sotalol is a first-line option for maintaining sinus rhythm in patients with atrial fibrillation who do not have significant heart failure or structural heart disease.
Sotalol is unique because it is 100% renally cleared; according to DailyMed (2024), its half-life can extend from 12 hours to over 48 hours in patients with severe kidney disease.
The FDA-approved labeling for Sotylize (2023) indicates that Sotalol is safe for use in pediatric patients as young as newborns, provided dosing is adjusted for body surface area and renal maturity.
Clinical data from the National Institutes of Health (NIH, 2024) shows that Sotalol is not metabolized by the liver, making it a preferred option for patients with hepatic impairment compared to other antiarrhythmics.
According to the Institute for Safe Medication Practices (ISMP, 2023), Sotalol is classified as a 'high-alert medication' because of the significant risk of causing serious harm when used incorrectly.
Research in the European Heart Journal (2021) suggests that maintaining serum potassium levels above 4.0 mEq/L is critical for reducing the risk of Sotalol-induced arrhythmias.
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Betapace Af, you must consult a qualified healthcare professional.
Clinical Information
Detailed information about Betapace Af
ℹ️Overview
Sotalol is a unique antiarrhythmic medication with both Class II (beta-adrenoceptor blocking) and Class III (cardiac action potential duration prolongation) properties, primarily used to manage life-threatening ventricular arrhythmias and maintain sinus rhythm in patients with atrial fibrillation.
💊Usage & Dosage
Adult Dosage
Dosage for Sotalol is highly individualized based on the patient's renal function and the specific arrhythmia being treated.
For Ventricular Arrhythmias: The typical starting dose is 80 mg twice daily (BID). If the initial response is inadequate after 3 days of monitoring, the healthcare provider may increase the dose to 120 mg or 160 mg twice daily. Most patients respond to a total daily dose of 160 mg to 320 mg. In some life-threatening cases, doses up to 480 mg to 640 mg per day may be used, though this significantly increases the risk of side effects.
For Atrial Fibrillation/Flutter (Betapace AF): The starting dose is usually 80 mg twice daily. The dose is adjusted based on the calculated creatinine clearance (a measure of kidney function) and the QTc interval (a measurement on an EKG). The maximum recommended dose for AFib is typically 160 mg twice daily.
Pediatric Dosage
Sotalol is approved for use in children for certain arrhythmias. Dosing in pediatrics is strictly based on Body Surface Area (BSA) and age. For children aged 2 years or older, the dose is generally calculated to be equivalent to the adult dose adjusted for BSA. For infants under 2 years of age, the dosage must be further reduced because the renal clearance mechanisms in infants are not fully developed. Pediatric treatment must only be managed by a pediatric cardiologist.
Dosage Adjustments
Renal Impairment
Because Sotalol is cleared entirely by the kidneys, dosage adjustments are mandatory for patients with decreased renal function.
Creatinine Clearance (CrCl) > 60 mL/min: Standard twice-daily dosing.
CrCl 40-60 mL/min: Dosing interval is usually extended to once daily (every 24 hours).
CrCl < 40 mL/min: Sotalol is generally contraindicated for the treatment of atrial fibrillation. For ventricular arrhythmias, the dosing interval may be extended to every 36-48 hours, or the drug may be avoided entirely.
Hepatic Impairment
Since Sotalol is not metabolized by the liver, no dosage adjustment is typically required for patients with liver disease. However, overall clinical status should still be monitored.
Elderly Patients
Older adults are more likely to have reduced renal function. Healthcare providers will typically perform a creatinine clearance test before starting Sotalol and monitor kidney function regularly to prevent drug accumulation and toxicity.
How to Take Sotalol
1Consistency is Key: Sotalol can be taken with or without food, but you should choose one way and stick to it every day. As mentioned, food can slightly decrease absorption, so consistency helps maintain stable blood levels.
2Swallow Whole: Tablets should be swallowed whole with a full glass of water. Do not crush or chew the tablets unless specifically instructed by your pharmacist, as this can alter the drug's release profile.
3Avoid Antacids: Do not take antacids containing aluminum or magnesium (like Maalox or Mylanta) within 2 hours of taking Sotalol, as they can significantly reduce the amount of medicine your body absorbs.
4Storage: Store at room temperature (68°F to 77°F) in a dry place away from light and moisture.
Missed Dose
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Never double the dose to catch up, as this significantly increases the risk of a dangerous heart rhythm abnormality (Torsades de Pointes).
Overdose
Signs of Sotalol overdose include extreme bradycardia (very slow heart rate), congestive heart failure, hypotension (very low blood pressure), bronchospasm (wheezing), and hypoglycemia (low blood sugar). In severe cases, it can lead to prolonged QT intervals and life-threatening ventricular tachyarrhythmias.
Emergency Measures: If an overdose is suspected, seek emergency medical attention immediately. Treatment usually involves gastric lavage, administration of activated charcoal, and intensive supportive care, including the use of a pacemaker or intravenous medications like isoproterenol or dopamine to support heart rate and blood pressure.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking Sotalol without medical guidance, as abrupt discontinuation can lead to severe heart complications.
⚠️Side Effects
Common Side Effects (>1 in 10)
Most patients taking Sotalol will experience some mild to moderate side effects as their body adjusts to the medication. Common side effects include:
Fatigue and Lassitude: A general feeling of tiredness or lack of energy, often due to the beta-blocking effect slowing the heart rate.
Bradycardia: A heart rate slower than 60 beats per minute. While often intended, it can cause lightheadedness if the rate becomes too slow.
Dyspnea: Shortness of breath, particularly during physical exertion.
Dizziness: A feeling of unsteadiness or spinning, especially when standing up quickly.
Headache: Mild to moderate head pain that typically subsides over time.
🔴Warnings
Important Safety Information
Sotalol is a high-alert medication that requires strict adherence to safety protocols. Patients must be aware that Sotalol is not a 'start and forget' medication; it requires active participation in monitoring and reporting symptoms to a cardiology team.
Black Box Warnings
The FDA has issued a Black Box Warning for Sotalol (Betapace and Betapace AF). The primary warning states that Sotalol can cause life-threatening ventricular arrhythmias, specifically Torsades de Pointes (TdP). To reduce this risk, patients must be placed in a facility for at least three days that provides continuous electrocardiographic (EKG) monitoring and has specialized staff available to perform cardiac resuscitation. This applies to both the initiation of the drug and any subsequent dose increases. Furthermore, Sotalol must not be substituted for Sotalol AF (and vice-versa) without consulting the specific prescribing information for each, as they have different labeling requirements.
Major Precautions
QT Prolongation
🔄Interactions
Contraindicated Combinations (Do Not Use Together)
Certain drugs must never be used with Sotalol because the risk of a fatal interaction is too high.
Other QT-Prolonging Agents: Combining Sotalol with drugs like Thioridazine, Ziprasidone, or certain Class I/III antiarrhythmics (e.g., Amiodarone, Dofetilide) can lead to extreme QT prolongation and Torsades de Pointes.
Specific Antibiotics: Sparfloxacin and Erythromycin (IV) are contraindicated due to the high risk of cardiac arrhythmias.
Serious Interactions (Monitor Closely)
Digoxin: Both Sotalol and Digoxin slow the heart rate and conduction through the AV node. Using them together increases the risk of severe bradycardia and heart block.
🚫Contraindications
Absolute Contraindications
There are several conditions where Sotalol must NEVER be used because the risks far outweigh any potential benefit:
1Asthma or Bronchospastic Conditions: Sotalol is a non-selective beta-blocker. It blocks beta-2 receptors in the lungs, which can cause life-threatening airway constriction in patients with asthma or severe chronic obstructive pulmonary disease (COPD).
2Sinus Bradycardia: If a patient already has a resting heart rate below 50 beats per minute, Sotalol can slow the heart to a dangerous level, leading to fainting or cardiac arrest.
3Second or Third-Degree Heart Block: Unless the patient has a functioning artificial pacemaker, Sotalol is contraindicated because it slows electrical conduction through the heart's AV node, which could stop the heart entirely.
👥Special Populations
Pregnancy
Sotalol is classified as FDA Pregnancy Category B (under the old system). Animal studies have not shown evidence of harm to the fetus, but there are no adequate and well-controlled studies in pregnant women. Sotalol does cross the placenta and can be found in amniotic fluid.
Risks: Use of Sotalol during pregnancy may result in the fetus having a slow heart rate (bradycardia), low blood pressure, or low blood sugar.
Clinical Decision: Sotalol should only be used during pregnancy if the potential benefit to the mother justifies the potential risk to the fetus. If used near the time of delivery, the newborn should be monitored for at least 48-72 hours for signs of beta-blockade.
Breastfeeding
Sotalol is excreted in human milk in high concentrations. Studies have shown that the amount of Sotalol in breast milk can be 3 to 5 times higher than the amount in the mother's blood.
🧬Pharmacology
Mechanism of Action
Sotalol is a unique 'hybrid' antiarrhythmic. It is a non-selective beta-adrenergic receptor antagonist (Class II) and a potassium channel blocker (Class III).
Molecular Level: It binds to the beta-1 receptors in the heart and beta-2 receptors in the lungs and blood vessels. Simultaneously, it blocks the IKr (rapid delayed rectifier) potassium channels in the cardiac myocytes.
Electrophysiology: By blocking potassium exit, it prolongs the repolarization phase (Phase 3) of the cardiac action potential. This increases the 'refractory period,' meaning the heart muscle takes longer to be ready for the next beat, which stops rapid, abnormal rhythms from taking over.
Pharmacodynamics
Dose-Response: The beta-blocking effects are evident at low doses (as low as 25 mg), while the Class III (potassium blocking) effects typically require higher doses (usually 160 mg or more per day).
Frequently Asked Questions
Common questions about Betapace Af
What is Sotalol used for?
Sotalol is primarily used to treat and prevent serious, life-threatening heart rhythm disorders. It is FDA-approved for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, and for the maintenance of normal sinus rhythm in patients with atrial fibrillation or atrial flutter. Because it has both beta-blocking and potassium-channel-blocking properties, it helps stabilize the heart's electrical activity. It is usually reserved for patients whose symptoms are severe or whose arrhythmias are life-threatening. Your cardiologist will determine if Sotalol is appropriate based on the specific type of irregular heartbeat you have.
What are the most common side effects of Sotalol?
The most common side effects of Sotalol include fatigue, slow heart rate (bradycardia), dizziness, and shortness of breath. Many patients also report headaches, a general feeling of weakness, or lightheadedness when standing up. These symptoms occur because the medication slows down the heart and reduces the effects of adrenaline on the body. While many of these side effects are mild and may improve over time, a very slow heart rate can sometimes lead to fainting. It is important to monitor your pulse and report any significant changes or extreme tiredness to your healthcare provider.
Can I drink alcohol while taking Sotalol?
Drinking alcohol while taking Sotalol is generally discouraged or should be done with extreme caution. Alcohol can enhance the blood-pressure-lowering effects of Sotalol, which may lead to severe dizziness, lightheadedness, or fainting. Additionally, alcohol is a known 'trigger' for atrial fibrillation in many people, which can counteract the benefits of the medication. Excessive alcohol consumption can also lead to dehydration and electrolyte imbalances, such as low potassium, which significantly increases the risk of dangerous heart rhythm side effects from Sotalol. Always consult your doctor before consuming alcohol while on this medication.
Is Sotalol safe during pregnancy?
Sotalol is considered a Category B medication, meaning animal studies haven't shown harm, but there isn't enough data in humans to guarantee safety. The drug does cross the placenta and can reach the developing fetus, potentially causing the baby to have a slow heart rate or low blood sugar after birth. Sotalol is also found in high concentrations in breast milk, which could affect a nursing infant. Therefore, it is only prescribed during pregnancy or breastfeeding if the benefit to the mother's heart health clearly outweighs the risks to the baby. If you are pregnant or planning to become pregnant, you must discuss alternative treatments with your cardiologist.
How long does it take for Sotalol to work?
Sotalol begins to have a beta-blocking effect (slowing the heart rate) within about 1 to 2 hours after the first dose. However, its full antiarrhythmic effect—the ability to keep the heart in a stable, normal rhythm—usually takes about 2 to 3 days of consistent dosing. This is because it takes several doses for the medication to reach a 'steady state' concentration in your bloodstream. For this reason, doctors usually require patients to stay in the hospital for the first three days of treatment to monitor the heart's response as the drug levels build up. Do not expect an immediate complete resolution of rhythm issues on day one.
Can I stop taking Sotalol suddenly?
No, you should never stop taking Sotalol suddenly. Abruptly discontinuing any beta-blocker can cause a dangerous 'rebound' effect where your heart rate and blood pressure spike rapidly. This can lead to severe chest pain (angina), a heart attack, or new, dangerous heart arrhythmias. If your doctor decides you should no longer take Sotalol, they will provide a specific schedule to gradually taper your dose over one to two weeks. This allows your heart to slowly readjust to the absence of the medication. Always follow your doctor’s specific instructions for stopping the drug.
What should I do if I miss a dose of Sotalol?
If you miss a dose of Sotalol, take it as soon as you remember. However, if it is almost time for your next scheduled dose (usually within a few hours), you should skip the missed dose and simply take the next one at the regular time. You should never take two doses at once to make up for a missed one. Taking a double dose significantly increases the risk of toxicity and dangerous heart rhythm abnormalities like Torsades de Pointes. If you miss more than one dose, contact your healthcare provider for specific instructions on how to restart your schedule safely.
Does Sotalol cause weight gain?
Weight gain is not a common direct side effect of Sotalol, but it can occur indirectly. Like other beta-blockers, Sotalol can cause fatigue and decreased exercise tolerance, which might lead to a less active lifestyle and subsequent weight gain. However, a more serious concern is sudden weight gain (e.g., 3 pounds in a day or 5 pounds in a week), which can be a sign of worsening heart failure or fluid retention. If you notice rapid weight gain accompanied by swelling in your ankles or shortness of breath, you should contact your doctor immediately, as this requires urgent medical evaluation.
Can Sotalol be taken with other medications?
Sotalol has many significant drug interactions, so it must be used cautiously with other medications. It should not be taken with other drugs that prolong the QT interval, such as certain antibiotics (erythromycin), antipsychotics, or other antiarrhythmics. It also interacts with blood pressure medications like Digoxin, Verapamil, and Diltiazem, which can dangerously slow the heart rate. Even over-the-counter antacids can interfere with how Sotalol is absorbed. It is vital to provide your doctor and pharmacist with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking to avoid dangerous interactions.
Is Sotalol available as a generic?
Yes, Sotalol is widely available as a generic medication in several tablet strengths (80 mg, 120 mg, 160 mg, and 240 mg). Generic versions are typically much more affordable than the brand-name versions like Betapace or Betapace AF. However, it is important to note that even when using the generic, the specific labeling for 'AF' (atrial fibrillation) vs. 'non-AF' use still applies. Your pharmacist will ensure you receive the correct generic version that corresponds to your doctor's prescription. Generic Sotalol is required by the FDA to have the same active ingredient and effectiveness as the brand-name drug.
Similar Medications
Other drugs with the same active ingredient (Sotalol)
Gastrointestinal Issues: Nausea, vomiting, diarrhea, or localized abdominal pain.
Sleep Disturbances: Insomnia or unusually vivid dreams/nightmares.
Chest Pain: Non-cardiac chest discomfort or worsening of existing angina.
Edema: Swelling in the ankles, feet, or legs due to fluid retention.
Visual Disturbances: Blurred vision or sensitivity to light.
Rare Side Effects (less than 1 in 100)
Mental Status Changes: Depression, confusion, or hallucinations.
Skin Reactions: Rash, pruritus (itching), or increased sweating.
Syncope: Sudden fainting spells, which may indicate a more serious underlying rhythm issue.
Raynaud’s Phenomenon: Coldness or tingling in the fingers and toes due to peripheral vasoconstriction.
Serious Side Effects — Seek Immediate Medical Attention
> Warning: Stop taking Sotalol and call your doctor immediately or seek emergency care if you experience any of these symptoms.
1Torsades de Pointes: This is a specific, life-threatening type of ventricular tachycardia associated with QT prolongation. Symptoms include sudden fainting, severe palpitations, or a feeling that the heart is 'flopping' in the chest.
2New or Worsened Arrhythmia: Sotalol is proarrhythmic, meaning it can sometimes cause the very heart rhythm problems it is meant to treat.
3Heart Failure: Symptoms include rapid weight gain (more than 3 pounds in a day), severe swelling in the legs, and inability to breathe while lying flat.
4Severe Bradycardia: A pulse that stays below 50 beats per minute, accompanied by extreme weakness or fainting.
5Bronchospasm: Severe wheezing or difficulty breathing, especially in patients with a history of asthma or COPD.
Long-Term Side Effects
Prolonged use of Sotalol may lead to a persistent decrease in exercise tolerance due to the chronic blockade of beta-receptors. Additionally, like other beta-blockers, Sotalol may mask the symptoms of hyperthyroidism (overactive thyroid) or hypoglycemia (low blood sugar in diabetics). Long-term monitoring of renal function is essential, as any decline in kidney health over the years will increase the concentration of Sotalol in the blood, raising the risk of toxicity.
Black Box Warnings
Sotalol carries a prominent FDA Black Box Warning regarding the risk of proarrhythmia.
In-Hospital Initiation: To minimize the risk of induced heart rhythm problems, Sotalol must be initiated (or the dose increased) in a facility that can provide continuous EKG monitoring and cardiac resuscitation. Patients are typically hospitalized for a minimum of three days.
QT Prolongation: Sotalol can cause a dose-related prolongation of the QT interval. If the QTc interval exceeds 500 milliseconds, the dose must be reduced or the drug discontinued.
Renal Function: Because the drug is cleared by the kidneys, calculating creatinine clearance prior to the first dose is mandatory to prevent life-threatening accumulation.
Report any unusual symptoms, especially fainting or severe dizziness, to your healthcare provider immediately.
: This is the most significant risk associated with Sotalol. The QT interval represents the time it takes for the heart's electrical system to recharge. If this takes too long, it can trigger a fatal rhythm. Risk factors for QT prolongation include female gender, age over 65, existing heart failure, and electrolyte imbalances.
Electrolyte Imbalance: Low levels of potassium (hypokalemia) or magnesium (hypomagnesemia) significantly increase the risk of Sotalol-induced arrhythmias. Patients who use diuretics (water pills) or have chronic diarrhea are at higher risk and must have their electrolytes checked frequently.
Bradycardia and Heart Block: Sotalol slows the conduction of electrical signals through the heart. It can cause excessively slow heart rates or 'heart block,' where signals are delayed or stopped between the heart's chambers.
Bronchospasm: Patients with reactive airway diseases, such as asthma or severe COPD, should generally avoid Sotalol. While it is somewhat selective at low doses, at therapeutic levels, it can block beta-2 receptors in the lungs, leading to severe airway constriction.
Diabetes Masking: Sotalol can mask the symptoms of low blood sugar (hypoglycemia), such as a rapid heartbeat or tremors. Diabetic patients must monitor their blood sugar more closely.
Monitoring Requirements
While taking Sotalol, you will need regular medical tests:
1EKGs: To monitor the QT interval and heart rate.
2Renal Function Tests: Blood tests (Creatinine/BUN) to ensure the kidneys are clearing the drug effectively.
3Electrolyte Panels: To ensure potassium and magnesium levels remain within the optimal range.
Driving and Operating Machinery
Sotalol can cause dizziness, fatigue, and blurred vision, especially during the first few weeks of treatment or after a dose increase. Do not drive or operate heavy machinery until you know how this medication affects you.
Alcohol Use
Alcohol should be used with extreme caution. Alcohol can increase the blood-pressure-lowering effects of Sotalol, leading to severe dizziness or fainting. Furthermore, excessive alcohol use can trigger atrial fibrillation, the very condition Sotalol is meant to prevent.
Discontinuation
Do not stop taking Sotalol suddenly. Abruptly stopping a beta-blocker can cause a 'rebound' effect, leading to severe chest pain (angina), heart attack (myocardial infarction), or dangerous spikes in blood pressure. If the drug must be stopped, your doctor will provide a tapering schedule to slowly decrease the dose over 1 to 2 weeks.
> Important: Discuss all your medical conditions, especially kidney disease and lung problems, with your healthcare provider before starting Sotalol.
Calcium Channel Blockers: Drugs like Verapamil and Diltiazem also slow the heart. Combining them with Sotalol can lead to dangerously low heart rates and hypotension.
Diuretics: Loop diuretics (like Furosemide) or Thiazides (like HCTZ) can deplete potassium and magnesium. Low electrolytes plus Sotalol is a recipe for life-threatening arrhythmias.
Beta-Agonists: Sotalol may block the effects of asthma medications like Albuterol, rendering them ineffective during an asthma attack.
Moderate Interactions
Insulin and Oral Hypoglycemics: Sotalol can prolong the hypoglycemic effect of these drugs and mask the warning signs of low blood sugar.
Clonidine: If Sotalol and Clonidine are taken together and Clonidine is stopped suddenly, it can cause a life-threatening spike in blood pressure. Sotalol should be stopped several days before Clonidine is tapered off.
Reserpine and Guanethidine: These older blood pressure meds can have an additive effect with Sotalol, causing excessive depletion of catecholamines and severe low blood pressure.
Food Interactions
Dairy Products and Calcium: High-calcium foods and milk can reduce the absorption of Sotalol by about 20%. It is best to take Sotalol consistently—either always with dairy or always without it—to keep blood levels stable.
Caffeine: While not a direct chemical interaction, caffeine is a stimulant that can trigger the arrhythmias Sotalol is trying to suppress. Limit intake of coffee, tea, and energy drinks.
Herbal/Supplement Interactions
St. John’s Wort: While Sotalol isn't metabolized by the liver, St. John's Wort can affect overall heart rate and should be avoided.
Magnesium/Aluminum Antacids: As noted, these can block Sotalol absorption. Wait at least 2 hours between taking an antacid and taking Sotalol.
Licorice Root: Can lead to potassium loss, increasing the risk of Sotalol toxicity.
Lab Test Interactions
Sotalol may interfere with certain lab tests. It can cause a false-positive result for urinary catecholamines when using certain testing methods (photometric methods). If you are being tested for an adrenal gland tumor (pheochromocytoma), ensure the lab knows you are taking Sotalol.
For each major interaction, the mechanism is usually pharmacodynamic (the drugs have additive effects on the heart's electrical system) rather than pharmacokinetic (interference with metabolism). The clinical consequence is typically an increased risk of heart failure, bradycardia, or sudden cardiac death.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold medicines which may contain stimulants.
4Congenital or Acquired Long QT Syndromes: Since Sotalol's primary effect is to prolong the QT interval, giving it to someone who already has a long QT interval is extremely dangerous.
5Cardiogenic Shock: In states of shock where the heart cannot pump enough blood, the beta-blocking effects of Sotalol will further decrease heart function and can be fatal.
6Severe Renal Impairment (CrCl < 40 mL/min for AFib): For patients with atrial fibrillation, Sotalol is contraindicated if kidney function is this low, as the drug will accumulate to toxic levels.
Relative Contraindications
These conditions require a careful risk-benefit analysis by a cardiologist:
Controlled Heart Failure: Sotalol can worsen heart failure, but in some cases, it may be used if the arrhythmia is more dangerous than the risk of worsening failure.
Diabetes: Requires careful monitoring due to the masking of hypoglycemia symptoms.
Peripheral Vascular Disease: May worsen symptoms of Raynaud's or claudication (leg pain when walking).
Thyroid Disease: Can mask symptoms of hyperthyroidism; abrupt withdrawal can trigger a 'thyroid storm.'
Cross-Sensitivity
Patients who have had a severe allergic reaction (anaphylaxis) to other beta-blockers (like Atenolol or Propranolol) should use Sotalol with extreme caution, although cross-reactivity is not always guaranteed. There is no known cross-sensitivity between Sotalol and sulfonamides, despite the structural similarity.
> Important: Your healthcare provider will evaluate your complete medical history, including EKG results and kidney function tests, before prescribing Sotalol.
Infant Risk: There is a significant risk of the nursing infant developing bradycardia or other beta-blocking effects.
Recommendation: Due to the potential for serious adverse reactions in the infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Sotalol is approved for use in children from birth through adolescence for the treatment of supraventricular and ventricular arrhythmias.
Dosing: Dosing is complex and must be adjusted for body surface area and age-related renal function.
Safety: The safety profile in children is generally similar to adults, though infants are at a much higher risk for drug accumulation due to immature kidneys. Continuous EKG monitoring during initiation is required for children just as it is for adults.
Geriatric Use
Elderly patients (over age 65) are at the highest risk for side effects from Sotalol.
Renal Clearance: The most significant concern is the natural decline in kidney function that occurs with age. This makes drug accumulation and subsequent QT prolongation much more likely.
Fall Risk: Dizziness and bradycardia can significantly increase the risk of falls and fractures in the elderly.
Polypharmacy: Older adults are more likely to be taking interacting medications like Digoxin or diuretics.
Renal Impairment
Renal impairment is the single most important factor in Sotalol toxicity.
Adjustments: For creatinine clearance between 40-60 mL/min, the dosing interval is doubled (once daily).
Contraindication: If CrCl is less than 40 mL/min, the drug is generally avoided for AFib.
Dialysis: Sotalol is removed by hemodialysis. A supplemental dose may be needed after a dialysis session, but this must be managed strictly by a specialist.
Hepatic Impairment
Because Sotalol is not metabolized by the liver, patients with liver cirrhosis or hepatitis generally do not require dose adjustments. However, these patients often have complex fluid and electrolyte balances that must be monitored to prevent secondary cardiac issues.
> Important: Special populations require individualized medical assessment and frequent monitoring of heart rhythm and kidney function.
Onset: Beta-blocking effects begin within 1-2 hours. The full antiarrhythmic effect on the heart's rhythm may take 2-3 days to stabilize as the drug reaches a 'steady state' in the blood.
Duration: The effects typically last 12-24 hours, which is why twice-daily dosing is standard for patients with normal kidney function.
Pharmacokinetics
| Parameter | Value |
|---|---|
| Bioavailability | 90% - 100% |
| Protein Binding | 0% |
| Half-life | 12 hours (increases with renal impairment) |
| Tmax (Time to Peak) | 2.5 - 4 hours |
| Metabolism | None (Not metabolized by liver) |
| Excretion | Renal (90-100% unchanged in urine) |
Chemical Information
Molecular Formula: C12H20N2O3S·HCl
Molecular Weight: 308.82 g/mol
Solubility: Highly soluble in water; poorly soluble in lipids (hydrophilic).
Structure: Sotalol is a methanesulfonanilide. It consists of a benzene ring with a methanesulfonamide group and a propanolamine side chain, which is characteristic of beta-blockers.
Drug Class
Sotalol is classified as a Class II/III antiarrhythmic. While it shares the '-olol' suffix with beta-blockers, its Class III properties make it pharmacologically distinct from drugs like Metoprolol or Atenolol. It is more closely related in function (though not structure) to drugs like Amiodarone or Dofetilide.